Catalyst Pharmaceutical Partners, a pharmaceutical company developing prescription drugs to treat addiction, filed for its IPO on Tuesday. First Albany and Stifel Nicolaus are set to manage the deal. Terms and timing have yet to be announced.
Catalyst Pharmaceutical Partners, a pharmaceutical company developing prescription drugs to treat addiction, filed for its IPO on Tuesday. First Albany and Stifel Nicolaus are set to manage the deal. Terms and timing have yet to be announced.